Biotechnology Industry News - Biotechblog

About
Publishing Opportunities
Archives
Regular Contributors
Biotechnology Books
Contact

Biotechnology Industry News

Comments are closed.

BiotechBlog’s Editor

Yali Friedman lives in Washington, DC and is author of the biotechnology business text book, Building Biotechnology. He also developed pharmaceutical business intelligence service DrugPatentWatch, is publisher of the Journal of Commercial Biotechnology.

Download FDA Orange Book Archives in PDF Format

Measuring Global Biotechnology

Speaking engagements and publishing opportunities

Search

Search the blog

Categories

Biotechnology Book Reviews
Books
Customer Success Stories
Drug Patent Litigation
Featured
General Biotechnology
Guest content
Infographic
Insights
Patent Added
Talks and Publications
Tentative Approval
Tips, Tricks, and Case Studies
Uncategorized
Update

Recent Posts

New patent for Genentech Inc drug EVRYSDI
New patent expiration for Optinose Us drug XHANCE
New tentative approval for Xiamen Lp drug topiramate
New patent for Eli Lilly drug ZEPBOUND
New patent for Myovant Sciences drug MYFEMBREE

Recent Comments

skfinston on Jim Greenwood on Data Exclusivity and Healthcare Innovation
Mudita Jain on Jim Greenwood on Data Exclusivity and Healthcare Innovation
Marcia Allen on Where are drugs invented? Globalization in the pharmaceutical industry
Fred Harrington on Which pharma companies have the most ‘New Dosage Form’ exclusivities?
Susan K. Finston on Mainstreaming the Microbiome – Part 2

© Copyright 2024 All rights reserved Biotechblog.
Responsive Deluxe developed by BriniDesigner